167 related articles for article (PubMed ID: 11752201)
1. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.
Loaiza-Pérez AI; Trapani V; Hose C; Singh SS; Trepel JB; Stevens MF; Bradshaw TD; Sausville EA
Mol Pharmacol; 2002 Jan; 61(1):13-9. PubMed ID: 11752201
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
3. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
4. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
[TBL] [Abstract][Full Text] [Related]
5. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
[TBL] [Abstract][Full Text] [Related]
7. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
10. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
Ciolino HP; Daschner PJ; Yeh GC
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
[TBL] [Abstract][Full Text] [Related]
11. Transient induction of increased aldehyde dehydrogenase 3A1 levels in cultured human breast (adeno)carcinoma cell lines via 5'-upstream xenobiotic, and electrophile, responsive elements is, respectively, estrogen receptor-dependent and -independent.
Sládek NE
Chem Biol Interact; 2003 Feb; 143-144():63-74. PubMed ID: 12604190
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
[TBL] [Abstract][Full Text] [Related]
13. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
14. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
[TBL] [Abstract][Full Text] [Related]
15. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes.
Lin P; Hu SW; Chang TH
Toxicol Sci; 2003 Jan; 71(1):20-6. PubMed ID: 12520072
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: A possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression.
Eltom SE; Zhang L; Jefcoate CR
Mol Pharmacol; 1999 Mar; 55(3):594-604. PubMed ID: 10051545
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor.
Burczynski ME; Penning TM
Cancer Res; 2000 Feb; 60(4):908-15. PubMed ID: 10706104
[TBL] [Abstract][Full Text] [Related]
18. Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells.
Taylor RT; Wang F; Hsu EL; Hankinson O
Toxicol Sci; 2009 Jan; 107(1):1-8. PubMed ID: 18842620
[TBL] [Abstract][Full Text] [Related]
19. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
Monteiro P; Gilot D; Langouet S; Fardel O
Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
[TBL] [Abstract][Full Text] [Related]
20. A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1, -1A2 and -1B1 by preventing activation of the aryl hydrocarbon receptor.
Sienkiewicz P; Ciolino HP; Leslie BJ; Hergenrother PJ; Singletary K; Yeh GC
Carcinogenesis; 2007 May; 28(5):1052-7. PubMed ID: 17183067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
